15.08.2022 - Trudhesa TRx’s Grew 48% in Q2 2022 to Over 13K: Net Product Revenue Increased 59% Over Q1 2022 to $2.8 Million Sales Force Expanded by 50% to Capitalize on Prescription Momentum and Market Opportunity Company Reiterated Prescription Guidance Range .
CALM 201 Study to Explore the Safety and Efficacy of Single 5mg-Dose INP105 Compared to Placebo in Quickly Reducing Agitation in Participants with ASD .
(BPT) - When a migraine hits, your life screeches to a halt. You want relief fast and consider taking your prescription pills, but you don t think you can keep them
(BPT) - When a migraine hits, your life screeches to a halt. You want relief fast and consider taking your prescription pills, but you don t think you can keep them